These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17451426)

  • 41. Balancing needs and means: the dilemma of the beta-cell in the modern world.
    Leibowitz G; Kaiser N; Cerasi E
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():1-9. PubMed ID: 19817783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mouse models created to study the pathophysiology of Type 2 diabetes.
    LeRoith D; Gavrilova O
    Int J Biochem Cell Biol; 2006; 38(5-6):904-12. PubMed ID: 16103004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between beta-cell mass and diabetes onset.
    Matveyenko AV; Butler PC
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4(0 4):23-31. PubMed ID: 18834430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus.
    Akash MS; Rehman K; Chen S
    J Cell Biochem; 2013 Mar; 114(3):525-31. PubMed ID: 22991242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review.
    Inaishi J; Saisho Y
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33339276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis.
    Wilkin TJ
    Pediatr Diabetes; 2012 Jun; 13(4):334-9. PubMed ID: 22059423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta blocker.
    Davenport RJ
    Sci Aging Knowledge Environ; 2005 Mar; 2005(12):nf22. PubMed ID: 15788791
    [No Abstract]   [Full Text] [Related]  

  • 48. Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):121-127. PubMed ID: 30173655
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apoptosis in pancreatic β-islet cells in Type 2 diabetes.
    Tomita T
    Bosn J Basic Med Sci; 2016 Aug; 16(3):162-79. PubMed ID: 27209071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical basis and clinical consequences of glucolipotoxicity: a primer.
    Srinivasan VA; Raghavan VA; Parthasarathy S
    Heart Fail Clin; 2012 Oct; 8(4):501-11. PubMed ID: 22999235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite?
    Malone JI; Hansen BC
    Pediatr Diabetes; 2019 Feb; 20(1):5-9. PubMed ID: 30311716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progenitor cells may aid successful islet compensation in metabolically healthy obese individuals.
    Singh H; Parthasarathy V; Farouk M; Venkatesan V
    Med Hypotheses; 2016 Jan; 86():97-9. PubMed ID: 26549352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Cell inflammation in human type 2 diabetes and the role of autophagy.
    Marselli L; Bugliani M; Suleiman M; Olimpico F; Masini M; Petrini M; Boggi U; Filipponi F; Syed F; Marchetti P
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():130-6. PubMed ID: 24003929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beyond the beta cell in diabetes.
    Hattersley AT
    Nat Genet; 2006 Jan; 38(1):12-3. PubMed ID: 16380722
    [No Abstract]   [Full Text] [Related]  

  • 55. Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes.
    Meier JJ; Bonadonna RC
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S113-9. PubMed ID: 23882035
    [No Abstract]   [Full Text] [Related]  

  • 56. Interaction of fast and slow dynamics in endocrine control systems with an application to β-cell dynamics.
    Wang YF; Khan M; van den Berg HA
    Math Biosci; 2012 Jan; 235(1):8-18. PubMed ID: 22063267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes.
    Muoio DM; Newgard CB
    Nat Rev Mol Cell Biol; 2008 Mar; 9(3):193-205. PubMed ID: 18200017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The beta-cell in type 2 diabetes and in obesity.
    Rutter GA; Parton LE
    Front Horm Res; 2008; 36():118-134. PubMed ID: 18230899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stressed out about obesity and insulin resistance.
    de Luca C; Olefsky JM
    Nat Med; 2006 Jan; 12(1):41-2; discussion 42. PubMed ID: 16397561
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of Ceramide in Apoptosis and Development of Insulin Resistance.
    Kuzmenko DI; Klimentyeva TK
    Biochemistry (Mosc); 2016 Sep; 81(9):913-27. PubMed ID: 27682164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.